These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 26239419)

  • 21. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
    Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.
    Zhang Z; Garron TM; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2009 Jun; 35(4):527-37. PubMed ID: 19167828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway.
    Ji X; Tang Z; Shuai W; Zhang Z; Li J; Chen L; Cao J; Yin W
    Life Sci; 2019 Aug; 231():116674. PubMed ID: 31344427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
    Wang X; Gao Z; Wu X; Zhang W; Zhou G; Liu W
    Pharm Biol; 2016 Jul; 54(7):1189-97. PubMed ID: 26135051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
    Sun GF; Li HC; Zhan YP; Zhang XF; Pan LY; Chen YF; Xu K; Feng DX
    Lab Invest; 2019 Dec; 99(12):1861-1873. PubMed ID: 31409891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Signal roles of protein tyrosine kinase in transforming growth factor-beta1, or interferon-gamma regulated proliferation and collagen synthesis by fibroblasts from hypertrophic scar and normal dermis].
    Zhang XF; Li HY; Lu KH; Guo SZ; Zhang LX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):36-9. PubMed ID: 15844596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
    Qian W; Li N; Cao Q; Fan J
    J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars.
    Matsui T; Ito C; Oda M; Itoigawa M; Yokoo K; Okada T; Furukawa H
    J Pharm Pharmacol; 2011 Jul; 63(7):960-6. PubMed ID: 21635262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
    Li Y; Yu Z; Zhao D; Han D
    Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of TRAP1-like protein involved in modulating fibrotic processes mediated by TGF-β/Smad signaling in hypertrophic scar fibroblasts.
    Wang X; Chu J; Wen CJ; Fu SB; Qian YL; Wo Y; Wang C; Wang DR
    Exp Cell Res; 2015 Mar; 332(2):202-11. PubMed ID: 25655281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.
    Chun Q; ZhiYong W; Fei S; XiQiao W
    Int Wound J; 2016 Apr; 13(2):257-62. PubMed ID: 24802644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of mechanical tension on the formation of hypertrophic scars in rabbit ears and transforming growth factor-β
    Cao P; Wang YW; Guan H; Yang YS; Li SH; Chen Y; Zhu C; Wan Y; Ren LY; Yao M
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Dec; 38(12):1162-1169. PubMed ID: 36594147
    [No Abstract]   [Full Text] [Related]  

  • 34. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
    Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
    Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.
    Wang X; Qian Y; Jin R; Wo Y; Chen J; Wang C; Wang D
    PLoS One; 2013; 8(2):e55899. PubMed ID: 23418473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and mechanistic investigation of Shikonin in scarring.
    Xie Y; Fan C; Dong Y; Lynam E; Leavesley DI; Li K; Su Y; Yang Y; Upton Z
    Chem Biol Interact; 2015 Feb; 228():18-27. PubMed ID: 25591861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop.
    Dabiri G; Tumbarello DA; Turner CE; Van de Water L
    J Invest Dermatol; 2008 Oct; 128(10):2518-25. PubMed ID: 18401422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways.
    Nie Y; Yang Y; Zhang J; Cai G; Chang Y; Chai G; Guo C
    Biomed Pharmacother; 2017 Nov; 95():1119-1128. PubMed ID: 28922731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad‑binding decoy reduces extracellular matrix expression in human hypertrophic scar fibroblasts.
    Fan C; El Andaloussi S; Lehto T; Kong KW; Seow Y
    Mol Med Rep; 2020 Dec; 22(6):4589-4600. PubMed ID: 33173952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Umbilical cord-derived mesenchymal stem cells exert anti-fibrotic action on hypertrophic scar-derived fibroblasts in co-culture by inhibiting the activation of the TGF β1/Smad3 pathway.
    Meng X; Gao X; Chen X; Yu J
    Exp Ther Med; 2021 Mar; 21(3):210. PubMed ID: 33574910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.